In a letter to the anti-pesticides activist group PAN Europe, EU Health Commissioner Tonio Borg backs the European Food Safety Authority's (EFSA) definition of endocrine-disrupting chemicals, saying ...

The European Parliament last week rejected a narrow definition of endocrine disruptors that would have allowed their use in some cases. The proposal—put forward by the European Commission, the EU’s ...

Nearly a year after the European Commission (EC) proposed criteria to define endocrine disruptors, experts say talks aimed at ultimately banning toxic chemical substances continue to be bogged down by ...

The Pesticide Action Network Europe (PAN Europe) has sent an open letter to the Commissioner for Health and Consumer Policy Tonio Borg complaining about an Opinion by the European Food Safety ...

MEPs today blocked a Commission proposal that would have exempted some chemicals from being identified as endocrine disruptors due to wider criteria. The Commission must now come up with a new ...

Diagnosing an endocrine disorder can be challenging because symptoms often mimic those of other conditions, and treatment plans can be complex. That’s why people with an endocrine disease need to see ...

The pancreas is a key metabolic regulator. When pancreatic beta cells cease producing enough insulin, blood sugar levels rise dangerously — a phenomenon known as hyperglycemia — thus triggering ...

The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated. Relationships are self-held unless noted. I = Immediate Family ...

(Beyond Pesticides, March 2, 2017) On Tuesday, the European Commission (EC) refrained from voting on proposed scientific criteria that would have identified endocrine disrupting chemicals (EDC) and ...

Expression of oestrogen receptor (ESR1) determines whether a breast cancer patient receives endocrine therapy, but does not guarantee patient response. The molecular factors that define endocrine ...

Women receiving endocrine therapy for hormone receptor (HR)–positive breast cancer or its prevention among those at high risk for breast cancer commonly have vasomotor symptoms. Data are lacking on ...